SIGLEC9 Polyclonal Antibody, AbBy Fluor-350 Conjugated, BF350, Rabbit

Artikelnummer: BSS-BS-9874R-BF350
Artikelname: SIGLEC9 Polyclonal Antibody, AbBy Fluor-350 Conjugated, BF350, Rabbit
Artikelnummer: BSS-BS-9874R-BF350
Hersteller Artikelnummer: bs-9874R-BF350
Alternativnummer: BSS-BS-9874R-BF350-100
Hersteller: Bioss
Wirt: Rabbit
Kategorie: Antikörper
Applikation: IF, WB
Spezies Reaktivität: Human
Konjugation: BF350
Alternative Synonym: CD329, CDw329, OB binding protein like, OBBP LIKE, Protein FOAP 9, Protein FOAP-9, sialic acid binding Ig like lectin 9, Sialic acid-binding Ig-like lectin 9, Sialic acid-binding immunoglobulin like lectin 9, SIGL9_HUMAN, Siglec 9, Siglec-9, SIGLEC9.
Two families of mammalian lectin-like adhesion molecules bind glycoconjugate ligands in a sialic acid-dependent manner: the selectins and the sialoadhesins. The sialic acid-binding immunoglobulin superfamily lectins, designated siglecs or sialoadhesins, are immunoglobulin superfamily members recognizing sialylated ligands. The common sialic acids of mammalian cells are N-acetyl-neuraminic acid (Neu5Ac) and N-glycolyl-neuraminic acid (Neu5Gc). Siglec-1 mediates local cell-cell interactions in lymphoid tissues and can be detected at contact points of macrophages with other macrophages, sinus-lining cells and reticulum cells. Siglec-7, highly expressed in monocytes and resident blood cells, but not in parenchymatous cells, mediates inhibition of natural killer cell cytotoxicity. Siglec-9 is closely homologous to Siglec-7, the gene encoding it maps to chromosome 19q13.41 in humans. It is highly expressed in peripheral blood leukocytes (but not eosinophils), liver, bone marrow, placenta and spleen. Siglec-8, a type I membrane protein, is selectively expressed on human eosinophils, basophils and mast cells, where it regulates their function and survival.
Klonalität: Polyclonal
Konzentration: 1ug/ul
NCBI: 27180
Puffer: Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Quelle: KLH conjugated synthetic peptide derived from human SIGLEC9
Target-Kategorie: SIGLEC9
Application Verdünnung: WB(1:300-5000), IF(IHC-P)(1:50-200)